Zheng, R., Yao, B., Ye, Y., Luo, R., Wu, Z., Hu, X., Yuan, Y., Pan, X., Liu, C., Huang, L., Luo, Y., Yang, D., Shang, N., Tian, Y. and Jia, J. 2024. MAL, a potential immunotherapy target, is associated with poor prognosis in cancer patients: A pan-cancer study of MAL. Cellular and Molecular Biology. 70, 4 (Apr. 2024), 248–254. DOI:https://doi.org/10.14715/cmb/2024.70.4.39.